Plasma gelsolin decreases with the progression of pregnancy and intrauterine inflammation and may particularly reflect the progression of intrauterine inflammation in cases of preterm premature rupture of membrane. Gelsolin has the potential to serve as a novel biomarker for detecting inflammatory conditions that are not readily identified by conventional markers.
Miyazaki et al. (Tue,) studied this question.